Physician Photo

Rochelle P. Walensky, MD, MPH

  • Phone: 617-726-3812
Infectious Diseases
Department of Medicine
Clinical Interests
HIV infection
Infectious disease
Boston: Massachusetts General Hospital
Medical Education
Harvard School of Public Health
MD, Johns Hopkins University School of Medicine
Residency, Johns Hopkins Hospital
Fellowship, Massachusetts General Hospital
Board Certifications
Infectious Disease, American Board of Internal Medicine
Patient Age Group
Accepting New Patients

In General Awards and Honors

MGH Hotline 4.2.10

Study suggests earlier HIV antiviral treatment saves lives and is cost effective, even in areas of limited resources

Early initiation of lifesaving antiretroviral therapies should be the standard of care for all HIV-infected patients, even those in countries with limited medical and financial resources, according to a study led by researchers at MGH and the Desmond Tutu HIV Centre, University of Cape Town, South Africa.

Universal HIV testing and immediate treatment could reduce but not eliminate HIV/AIDS epidemic

Implementing universal HIV testing and immediate antiretroviral treatment for infected individuals could have a major impact on the HIV/AIDS epidemic in Washington, DC but not halt the epidemic, which a previous report had projected.

Generic HIV treatment strategy could save nearly $1 billion annually but may be less effective

Replacing the combination of brand-name, antiretroviral drugs currently recommended for control of HIV infection with soon-to-be-available generic medications could save the U.S. health care system almost $1 billion a year but may diminish the effectiveness of HIV treatment.

Early HIV antiviral treatment found to be cost-effective in South Africa, India

"Treatment as prevention" – early initiation of antiretroviral therapy (ART) for HIV-infected individuals with uninfected sexual partners to prevent viral transmission – appears to make economic sense, along with meeting its clinical goals of helping infected patients stay healthy and reducing transmission.

Study Highlights Massive Benefits of HIV Treatment in South Africa

Antiretroviral therapy for the treatment of HIV infection has saved 2.8 million years of life in South Africa since 2004 and is projected to save an additional 15.1 million years of life by 2030, according to a new study published online in The Journal of Infectious Diseases.

Point-of-care CD4 testing is economically feasible for HIV care in resource-limited areas

A study by Massachusetts General Hospital investigators, working in collaboration with colleagues in Mozambique and South Africa, indicates that routine point-of-care CD4 testing at the time of HIV diagnosis could be cost effective in countries where health care and other resources are severely limited.

Infectious Disease Associates
55 Fruit Street
Boston, MA 02114-2696

Phone: 617-726-3812